Abstract
Since the introduction of the long acting benzothiadiazine diuretics by Novello and Sprague in 1957 and the demonstration of their blood pressure lowering actions (Hollander and Wilkins, 1957; Freis et al., 1958), a vast literature has developed attesting to this effect, though considerable controversy has surrounded the mode of action. The fall in blood pressure, however, is quite modest, approximately 20/12 mmHg in the recumbent and standing positions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aleksandrow, D., Wysznacka W., Gajewski, J.: Studies on the mechanism of hypotensive action of chlorothiazide. New Engl. J. Med. 260, 51–55 (1959a).
Aleksandrow, D., Wysznacka, W., Gajewski,J.: Influence of chlorothiazide upon arterial responsiveness to nor-epinephrine in hypertensive subjects. New Engl. J. Med 261, 1052–1055 (1959b).
Anderson, J., Godfrey, B.E., Hill, D.M., Mtjnro-Fattre, A.D., Sheldon, J.: A comparison of the effects of hydrochlorothiazide and Frusemide in the treatment of hypertensive patients. Quart. J. Med. NS 40, 541–560 (1971).
Aoki, V.S., Brody, M. J.: Effect of thiazides on the sympathetic nervous system. Pharmacologist 7, 145 (1965) (Abstract).
Bartorelli, C, Gargano, N., Leonetti, G.: Potassium loss and potassium replacement during long-term diuretic treatment in hypertension. In: Antihypertensive Therapy. An International Symposium. F. Gross (Ed.). Berlin-Heidelberg-New York: Springer 1966.
Birkenhager, W.H., Statitjs van Eps, L.W., Vries, L.A. de: Reversal of rhythmic water and sodium excretion patterns during ganglionic or adrenergic block. Acta med. scand. 172, 105–115 (1962).
Borhani, N.O.: Chlorothiazide and hydrochlorothiazide. A comparative study of their hypotensive, saluretic and hyperuricemic action. Ann. intern. Med. 53, 342–358 (1960).
Borst, J.G.G., Geus, A.B.: Hypertension explained by Starling’s theory of circulatory homeostasis. Lancet 1963 I, 677–682.
Botjrgoignie, J.J., Catanzaro, F. J., Perry, H.M.: Renin-Angiotensin Aldosterone System during chronic thiazide therapy of benign hypertension. Circulation 37, 27–35 (1968).
Bravo, E.L., Tarazi, R.C, Dustan, H.P.: Beta-adrenergic blockade in diuretic-treated patients with essential hypertension. N. Engl. J. Med., 292, 66–70 (1975).
Brown, J. J., Davis, D.L., Ferriss, J.B., Fraser, R., Haywood, E., Lever, A.F., Robertson, J. LS.: Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess and low plasma renin. Brit. med. J. 1972, II, 729–734.
Brown, J. J., Davies, D.L., Lever, A.F., Robertson, J.I.S.: Plasma renin concentration in human hypertension. Brit. med. J. 1966, II, 267–272.
Brown, W.J., Brown, F.K., Krishnan, I.: Exchangeable sodium and blood volume in normo-tensive and hypertensive humans on high and low sodium intake. Circulation 43, 508–519 (1971).
Bühler, F.R., Burkart, F., Lütold, B.E., Küng, M., Marbet, G., Peisterer, M.: Antihypertensive beta-blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. Amer. J. Cardiol., 36, 653–669 (1975).
Bühler, F.R., Laragh, J.H., Sealey J.E., Brtjnner, H.R.: Plasma aldosterone-renin interrelationship in various forms of essential hypertension. Amer. J. Cardiol. 32, 554–561 (1973).
Carey, R.M., Douglas, J. G., Liddle, G.W.: Spironolactone in patients with essential hypertension and suppressed plasma renin activity. Clin. Res. 20, 72 (1972) (abstract).
Castenfors, J.: Effect of ethacrynic acid on plasma renin activity during supine exercise in normal subjects. Acta physiol. scand. 70, 215–220 (1967).
Castle, C.H., Conrad, J.K., Hecht, H.H.: Observations on the diuretic effect of chlorothiazide. Arch, intern. Med. 103, 415–420 (1959).
Catt, K.J., Cain, M.D., Coghlan, J.P., Zimmet, P.Z., Crain, E., Best, J.B.: Metabolism and blood levels of Angiotensin II in normal subjects, Renal Disease and essential hypertension. Circulation Res. 26 and 27, Suppl. II, 177–193 (1970).
Catt, K.J., Zimmet, P.Z., Cain, M.D., Cran, E., Best, J.B., Coghlan, J.P.: Angiotensin II blood-levels in human hypertension. Lancet 1971I, 459–469.
Chamberlain, D.A., Howard, J.: Guanethidine and methyldopa: a haemodynamic study. Brit. Heart. J. 26, 528–536 (1964).
Channick, B. J., Aldin, E. V., Marks, A.D.: Suppressed plasma renin activity in hypertension Ann. intern. Med. 123, 131–140 (1969).
Coghlan, J.P., Doyle, A.E., Jerums, J., Scogginö, B.A.: The effects of sodium loading and deprevation on plasma renin and plasma and urinary aldesterone in hypertension. Clin. Sci. 42, 15–23 (1972).
Colwill, J.M., Dtjtton, A.M., Morrissey, J., Yu, P.N.: Alpha-methyldopa and hydrochlorothiazide. New Engl. J. Med. 271, 696–703 (1964).
Conway, J., Latjwers, P.: Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide. Circulation 21, 21–27 (1960).
Conway, J., Leonetti, G.: Hypotensive effect of ethacrynic acid. Circulation 31, 661–664 (1965).
Conway, J., Palmero, H.: The vascular effect on the thiazide diuretics. Arch, intern. Med. 111, 203–207 (1963).
Cranston, W. I., Jtjel-Jensen, B.E.: The effects of spironolactone and chlorthalidone on arterial pressure. Lancet 1962 I, 1161–1164.
Cranston, W. I., Juel-Jensen, B, E, Semmence, A, M, Jones, R.P.C.H., Forbes, J. A., Mutch, L.M.M.: Effect of oral diuretis on raised arterial pressure. Lancet 1963 II, 966–970.
Cranston, W.I., Semmence, A.M., Richardson, D.W., Barnett, C.F.: Effect of triamterene (Dyrenium) on elevated arterial blood pressure. Amer. Heart. J. 70, 455–460 (1965).
Creditor, N.C., Loschky, U.K.: Incidence of suppressed renin activity and of normo-kalemic primary aldosteronism in hypertensive negro patients. Circulation 37, 1027–1035 (1968).
Crosley, A.P., Jr., Costello, C., Freeman, J. D., White, D.H., Jr., Rowe, G.C: The acute effects of carbonic anhydrase inhibitors on systemic hemodynamics. J. clin. Invest. 37, 887 (1958) (abstract).
Crosley, A.P., Jr., Ctjllen, R.C, White, D., Freeman, J.J., Castillo, C.A., Rowe, G.C: Studies on the mechanism of action of chlorothiazide in cardiac and renal diseases. I. Acute effects on renal and systemic hemodynamics and metabolism. J. Lab. clin. Med. 55, 191–202 (1960).
Daniel, E.E.: On the mechanism of antihypertensive action of hydrochlorothiazide in rats. Circulation Res. 11, 941–954 (1962).
Daniel, E.E., Nash, C.W.: The effect of diuretic and non-diuretic benzothiadiazines and of structurally related diuretic drugs on active ion transport and contractility in smooth muscles. Arch. Int. Pharmacodyn. 158, 139–154 (1965).
Darracott Vaughan, E., Laragh, J.H., Gavras,L, Buhler, F.R., Haralambos, G., Brun-ner, H.R., Baer, J.: Volume factor in low and normal renin essential hypertension. Amer. J. Cardiol. 32, 523–532 (1973).
Davidov, M., Gavrilovich, L., Mroczek, W., Finnerty, F.A., Jr.: Relation of extracellular fluid volume to arterial pressure during drug-induced saluresis. Circulation 40, 349–355 (1969).
Davidov, M., Kakaviatos, N., Finnerty, F.A., Jr.: Antihypertensive properties of furosemide. Circulation 34, 125–135 (1967).
Davies, D.L., Wilson, G.M.: Diuretics: Mechanism of action and clinical application. Drugs 9, 178–226 (1975).
Dollery, C.T., Parry, E.H.O., Young, D.S.: Diuretic and hypotensive properties of ethacrynic acid: A comparison with hydrochlorothiazide. Lancet 1964 I, 947–952.
Dustanjh P., Ctjmming, G.R., Corcoran, A.C., Page, LH.: A mechanism of chlorothiazide enhanced effectiveness of antihypertensive, ganglioplegic drugs. Circulation 19, 360–365 (1959).
Dtjstan, H.P., Tarazi, R.C., Bravo, E.L.: Dependence of arterial pressure on intravascular volume in treated hypertensive patients. New Engl. J. Med. 286, 816–866 (1972).
Eckstein, J. W., Wnedling, M.G.: Effect of prolonged treatment with chlorothiazide on cardiovascular responses to norepinephrine, J. Lab. clin. Med. 64, 853–854 (1964
Feisal, K.A., Eckstein, J. W., Horsley, A.W., Keasligh, H.H.: Effects of chlorothiazide on forearm vascular responses. J. appl. Physiol. 16, 549–552 (1961).
Finnerty, A., Jr.: Relationship of extracellular fluid volume to the development of drug resistance in the hypertensive patient. Amer. Heart J. 81, 563–565 (1971).
Finnerty, F. A., Jr., Davidov, M., Kakaviatos, N.: Relation of sodium balance to arterial pressure during drug-induced saluresis. Circulation 37, 175–183 (1968).
Fregley, M. J.: Effect of chlorothiazide and hydrochlorothiazide on blood pressure and thyroid activity of hypertensive rats. Amer. J. Cardiol. 8, 890–898 (1961).
Freís, E.D., Wanko, A., Schnaper, H.W., Fröhlich, E.D.: Mechanism of the altered blood pressure responsiveness produced by chlorothiazide. J. clin. Invest. 39, 1277–1281 (1960).
Freís, E.D., Wanko, A., Wilson, I.M., Parrish, A.E.: Treatment of essential hypertension with chlorothiazide (Diuril). J. Amer. med. Ass. 166, 137–140 (1958).
Friedman, S.M., Nakashima, M., Friedman, C.L.: Relation of saluretic and hypotensive effects of hydrochlorothiazide. Amer. J. Physiol. 198, 148–152 (1960).
Gessler, U., Neuhatjs, M.: Experimentelle Untersuchungen intra- und extracellularer Elektrolyt- und Wassergehaltsveränderungen nach Chlorthalidonbehandlung. Arch. exp. Path. Pharmakol. 244, 63–70 (1962).
Gipford, R.W., Mattox, V.R., Orvis, A.L., Sones, D.A., Rosevear, J.W.: Effect of thiazide diuretics on plasma volume, body electrolytes, and excretion of aldosterone in hypertension. Circulation 24, 1197–1205 (1961).
Gillenwater, J.Y., Scott, J.B., Fröhlich, E.D.: Effect of chlorothiazide on response of renal vascular bed to vasoactive substances. Circulation Res. 11, 283–286 (1962).
Gilmore, E., Weil, J., Chidsey, C.: Treatment of essential hypertension with a new vasodilator in combination with betaadrenergic blockade. New Engl. J. Med. 282, 521–527 (1970).
Hall, R., Owen, S.G.: The hypotensive effect of chlorothiazide. Lancet 1959 I, 129–130.
Hansen, J.: Hydrochlorothiazide in the treatment of hypertension. Acta med. scand. 183, 317–321 (1968).
Harington, M., Kinöaid-Smith, P.: Effect of chlorothiazide on the hypotensive action of mecamylamine and on its urinary excretion. Lancet 1958 I, 403–404.
Healy, J.J., McKenna, T.J., Canning, B.St, Jr., Brien, T.G., Dttffy, G.J., Mtjldowney, F.P.: Body composition changes in hypertensive subjects on long-term oral diuretic therapy. Brit. med. J. 1, 716–719 (1970).
Heider, C., Dennis, E., Moyer, J.H.: Chlorothiazide potentiation and ganglionic blockade in patients with hypertension. Ann. N. Y. Acad. Sci. 71, 456–464 (1958).
Helmer, O.M., Judson, W.E.: Metabolic studies on hypertensive patients with suppressed plasma renin activity not due to hyperaldosteronism. Circulation 28, 965–976 (1968).
Hitzenberger, G., Kampffmeyer, H., Conway, J.: The diuretic effect of desmethyl-pipazurol-guanidine (MK-870) in man. J. clin. Pharm. Therap. 9, 71–79 (1968).
Hollander, W.: The antihypertensive activity of aldosterone antagonists. In: Brest, A.N., Mover, J.H. (Eds.): Hypertension recent advances, pp. 269–274. Lea and Febiger 1961.
Hollander, W., Chobanian, A.V., Wrlkins, R.W.: Relationship between diuretic and antihypertensive effects of chlorthiazide and mercurial diuretics. Circulation 19, 827–838 (1959).
Hollander, W., Welkins, R.: Chlorothiazide: A new type of drug for the treatment of arterial hypertension. Boston Med. Quart. 8, 69–73 (1957).
Hollander, W., Yagi, S., Kramsch, D.M.: In vitro effects of vasopressor agents on the metabolism of the vascular wall. Circulation 30 (Supp. II), 1–10 (1964).
Hutcheon, D.E., Leonard, G.B., Schwartz, M.L.: The antihypertensive action of chlorthalidone. J. med. Soc. N. J. 62, 172–175 (1965).
Jertjms, G., Doyle, A. E.: Renal sodium handling and responsiveness of plasma renin levels in hypertension. Clin. Sci. 37, 79–90 (1969).
Jose, A., Crottt, J.R., Kaplan, N.M.: Suppressed plasma renin activity in essential hypertension. Ann. intern. Med. 72, 9–16 (1970).
Jtjngling, K.: Klinische Untersuchungen mit dem neuen Antihypertonikum, Catapresan. Med. Welt 39, 2105–2112 (1968).
Kakaviatos, N., Finnerty, F.A.: Comparison of chlorthalidone, a long-acting antihypertensive and diuretic agent with chlorothiazide. Amer. J. Cardiol. 101, 570–574 (1962).
Kampffmeyer, H., Conway, J.: The antihypertensive and diuretic effects of amiloride (N-amidino-3, 5-diamino-6-chlorophrazine-carboxamide hydrochloride alone and in combination with hydrochlorothiazide. J. Clin. Pharm. Therap. 9, 350–354 (1968).
Kaneko, Y., Takeda, T., Ikeda, T., Tagawa, H., Ishi, M., Takabatake, Y., Ueda, H.: Effect of ganglion-blocking agents on renin release in hypertensive patients. Circulation Res. 27, 97–103 (1970).
Laragh, J.H.: Symposium on hypertension: Mechanisms and Management. Vacocontriction Volume analysis for understanding and treating hypertension: The use of renin and aldosterone profiles. Amer. J. Med. 55, 261–274 (1973).
Lahler, D.P., Vagntjcci, A.L, Hickler, R.B., Thorn, G.W.: Clinical features of sodium retention induced by antihypertensive therapy. Circulation 28, 754–756 (1963).
Lattwers, P., Conway, J.: Effect of long-term treatment with chlorothiazide on body fluids, serum electrolytes and exchangeable sodium in hypertensive patients. J. Lab. clin. Med. 56, 401–406 (1960).
Lebel, M., Schalekamp, M.A., Beevers, D.G., Brown, J.J., Davies, D.L., Fraser, R., Kremer, D., Lever, A.F., Morton, J.J., Robertson, J.I.S., Tree, M., Wilson, A.: Sodium and the renin-angiotensin system in essential hypertension and mineralocorticoid excess. Lancet 1974 II, 308–310.
Leishman, A.W.D., Mathews, H.L., Smith, A. J.: Guanethidine Hypotensive drugs with long action. Lancet 1961 II, 1044–1048.
Leth, A.: Changes in plasma and extracellular fluid volumes in patients with essential hypertension during long-term treatment with hydrochlorothiazide. Circulation 42, 479–485 (1970).
Leth, A., Ibsen, H., Sederberg-Olsen, P.: The effect of triamterene on plasma and extracellular fluid volume and blood pressure in ten thiazide-treated hypokalemic patients with essential hypertension. Scand. J. clin. Lab. Invest. 30, 437–440 (1972).
Lund-Johansen, P.: Hemodynamic changes in long term diuretic therapy of essential hypertension. Acta med. scand. 187, 509–518 (1970).
McLeod, P.J., Ogilvie, R.L, Ruedy, J.: Effects of large and small doses of hydrochlorothiazide in hypertensive patients. J. clin. Pharm. Therap. 11, 733–739 (1970).
McQueen, E.G., Morrison, R.B.I.: The hypotensive action of diuretic agents. Lancet 1960 I 1209–1212.
Mohammed, S., Fasola, A F., Privitera, P.J., Lrpicky, R.J., Martz, B.L., Gaffney, T.E.: Effect of methyldopa on plasma renin activity in man. Circulation Res. 25, 543–547 (1969).
Molzahn, M., Pressmann, T.H., Halim, S., Lohmann, F.W., Oelkers, W.: Orthostatic changes of haemodynamics, renal function, plasma catecholamine and plasma renin concentration in normal and hypertensive man. Clin. Soi. 42, 209–222 (1972).
Nicholas, T. E.: Responses of mean arterial pressure to pressor agents and diuretics in renal hypertensive and salt hypertensive rats. Brit. J. Pharmacol. 42, 179–192 (1971).
Novello, F.C, Sprague, J.M.: Benzothiadiazine dioxides as novel diuretics. J. Amer. cxem. Soc. 79, 2028–2029 (1957).
Oelkers, W., Magnus, R., Samwer, K.F.: Das Verhalten der Plasmareninkonzentration nach akuter Natriurese und nach Orthostase bei Gesunden und Hypertonikern. Klin. Wschr. 48, 598–607 (1970).
Onesti, G., Schwartz, A.B., Kim, K.E., Swartz, C., Brest, A.N.: Pharmacodynamic effects of a new, antihypertensive Drug, Catapres (ST-155). Circulation 39, 219–228 (1969).
Orbison, J.L.: Failure of chlorothiazide to influence tissue electrolytes in hypertensive and non-hypertensive nephrectomized dogs. Proc. Sec. Exp. biol. Med. 110, 161–164 (1962).
Overturp, M., Fritz, A., McBride, J.: Renin activity, sodium and potassium in hypertensive patients. J. Chron. Dis. 25, 621–634 (1972).
Parus, J., Joossens, J.V., Van der Linden, Versteken, G., Amery, A.K.P.C: Moderate sodium restriction and diuretics in the treatment of hypertension. Amer. Heart J. 85, 22–34 (1973).
Paterson, J.W., Dollery, C.T., Haslam, R.M.: Amiloride hydrochloride in hypertensive patients. Brit. med. J. 1, 422–423 (1968).
Peters, G.: Pharmacology of diuretics. In: Gross, F. (Ed.): Antihypertensive Therapy. An International Symposium. Berlin-Heidelberg-New York: Springer 1966.
Peters, G., Roch-Ramel, F.: Handbook of experimental pharmacology. Herken, H. (Ed.). Vol. 24, p. 257–435. Heffter and Heubner 1969.
Pohl, J.E.F., Thurston, H., Swales, J.D.: The antidiuretic action of diazoxide. Clin. Sci. 42, 145–152 (1972).
Preziosi, E., Bianchi, A., Loscalzo, B., Schaepdryver, de, D.F.: On the pharmacology of chlorothiazide. Arch. int. Pharmacodyn. 118, 467–495 (1959).
Preziosi, E., Shaepdryver, A.F., de, Marmo E., Miele, E.: On the mechanism of the antihypertensive effect of hydrochlorothiazide. Arch. int. Pharmacodyn. 131, 209–229 (1961).
Remenchik, A.P., Miller, C., Talso, P. J., Willoughby, E.O.: Depletion of body potassium by diuretics. Circulation 33, 796–801 (1966).
Rønnov-Jessen, V.: Heart failure from retention of salt and water caused by treatment with pentolinium. Lancet 1955 I, 122–124.
Rønnov-Jessen, V., Hansen, J.: Blood volume and exchangeable sodium during treatment of hypertension with guanethidine and hydrochlorothiazide. Acta med. scand. 186, 155–163 (1969).
Rubin, A. A., Roth, F.E., Winbury, M.M.: A non-diuretic benzothiadiazine with antihypertensive properties. Nature (Lond.) 192, 176–177 (1961).
Safar, M., Milliez, P.: Le traitement médical de l’hypertension artérielle: étude hémodynamique. Rev. Europ. Etudes Clin. Biol. 16, 334–342 (1971).
Saito, I., Misumi, J., Kondo, K., Saruta, T., Matsuki, S.: Effects of furosemide and chlorothiazide on blood pressure and plasma renin activity. Cardio. Res. 10, 149–152 (1976).
Schwartz, W.B.: Pathogenesis and replacement of diuretic-induced potassium and chloride loss. Ann. N.Y. Acad. Sci. 139, 506–510 (1966).
Seriu, Y.: A clinical study of the role of catecholamine in blood pressure. Jap. Circulation J. 29, 433–488 (1965).
Shalekamp, M.A., Ledel, M., Beevers, D.G., Fraser, R., Kolsters, G., Birkenhäger, W.H.: Body fluid volume in low-renin hypertension. Lancet 1974 II, 310–311.
Smith, A.J.: Fluid retention produced by guanethedine. Circulation, 31, 490–496 (1965).
Smith, W.M., Bachman, B., Galante, J.G., Hanowell, E.G., Johnson, W.P., Kooh, C.E., Jr., KorfmaCher, S.D., Thurm, R.H., Bromer, L.: Co-operative Clinical Trial of aplha-methyldopa. Ann intern. Med. 65, 657, 671 (1966).
Smith, W.M., Damato, A.M., Galluzzi, N.J., Garfield, C.F., Hanowell, E.G., Stimson, W.H., Thurm, R.H., Walsh, J. J., Bromer, L.: The evaluation of antihypertensive therapy co-operative clinical trial method I. Double-blind control comparison od chlorothiazide, rauwolfia serpentina, and hydralazine. Ann. intern. Med. 61, 829–846 (1964).
Spark, R.F., Melby, J.C.: Hypertension and low renin activity: presumptive evidence for mineralocorticoid excess. Am. J. intern. Med. 75, 831 (1971).
Stanton, H.C., White, J.B., Jr.: Hypotensive actions of drug on unanaesthetized normotensive and “metacorticoid” hypertensive rats, determined by a direct recording technique. Arch. int. Pharmacodyn. 154, 351–363 (1965).
Swales, J. D.: Sodium Metabolism in Disease. Lloyd-Luke 1975.
Szwed, J.J., Kleit, S.A., Hamburger, R. J.: Effect of furosemide and chlorothiazide on the thoracic duct lymph flow in the dog. J. Lab. clin. med. 79, 693–700 (1972).
Talso, P. J., Carballo, A. J.: Effects of benzothiadiazines on serum and total body electrolytes. Ann. N.Y. Acad. Sci. 88, 822–840 (1960).
Talso, P. J., Remenchick, A.P., Ctjtilletta, A.F.: Effects of diuretic agents on serum and tissue electrolytes in rats. Proc. Soc. exp. Biol. (N.Y.) 122, 78–81 (1966).
Tapia, F. A., Dtjstan, H. P., Schneckloth, R. A., Corcoran, A. C., Page, L.H.: Enhanced effectiveness of ganglion-blocking agents in hypertensive patients during the administration of a saluretic agent (chlorothiazide). Lancet II, 1831–1833. (1957)
Tarazi, R.C, Dtjstan, H.P.: Beta adrenergic blockade in hypertension. Amer. J. Cardiol. 29 633–640 (1972).
Tarazi, R.C., Dtjstan, H.P., Fröhlich, E.D.: Long-term thiazide therapy in essential hypertension. Circulation 41, 709–717 (1970).
Taylor, R.D., Dtjstan, H.P., Corcoran, A.C., Page, I.H.: Evaluation of 1-hydrazinophlhal-azine (Apresoline) in treatment of hypertensive disease. Arch, intern. Med. 90, 734–749 (1952).
Tobian, L., Coffee, K.: Effect of thiazide drugs on renovascular hypertension in contrast to their effect in essential hypertension. Proc. Soc. exp. Biol. 119, 196–198 (1964).
Tobian, L., Janecek, J., Foker, J., Ferreira, D.: Effect of chlorothiazide on renal juxtaglomerular cells and tissue electrolytes. Amer. J. Physiol. 202, 905–908 (1962).
Varnatjskas, E., Cramer, G., Malmcrona, R., Werko, L.: Effect of chlorothiazide on blood pressure and blood flow at rest and on exercise in patients with arterial hypertension. Clin. Sci., 20, 407–416 (1961).
Venning, E. H., Dyrenfurth, L, Dossetor, J., B. Beck, J. C.: Effect of chlorothiazide upon, aldosterone excretion an Na and K balance in essential hypertension. J. Lab. clin. Med. 60, 79–85 (1962).
Veyrat, R., de Champlain, Boucher, R., Genest, J.: Measurement of human arterial renin activity in some physiological and pathological states. Canad. med. Ass. J. 90, 215–219 (1964).
Viersma, H. J.: De behandeling van hypertensie met zoutloos diet en met uidrijving van keu-kenzout. Amsterdam: N.V. Noord-Hollandsche Uitgevers Maatschappij 1946.
Villamll, M.F., Yeyati, N., Enero, M.A., Rtjbianes, S., Taqtjini, A.G.: Effect of long term treatment with hydrochlorothiazide on water and electrolytes. Amer. Heart J. 65, 194–207 (1963).
Villarreal, J., Exaire, J.E., Revollo, A., Soni, J.: Effects of chlorothiazide on systemic hemodynamics in essential hypertension. Circulation 26, 405–408 (1962 a).
Villarreal, H., Exaire, J.E., Rtjbio, V., Davila, H.: Effect of guanethidine and bretylium tosylate on systemic and renal hemodynamics in essential hypertension. Amer. J. Cardiol. 14, 633–643 (1964).
Villarreal, H., Revollo, A., Exaire, J.E., Larrondon, F.: Effects of chlorothiazide on renal hemodynamisc. Circulation 26, 409–412 (1962b).
Weinberger, H., Dowdy, A. J., Nokez, G.W., Leutscher, J.A.: Plasma renin activity and aldosterone secretion in hypertensive patients during high and low sodium intake and administration of diuretic. J. clin. Endocr. 28, 357–371 (1968).
Weller, J.M., Haight, A.S.: Effect of chlorothiazide on blood pressure and electrolytes of normotensive and hypertensive rats. Proc. Soc. exp. Biol. 112, 820–825 (1963).
Werning, C., Batjmann, K., Schönbeck, M., Gysling, E., Weldmann, P., Siegenthaler,W.: Die Wirkung länger dauernder Hydrochlorothiazid-Gaben auf die Plasma-Renin-Aktivität und die Aldosteronexkretionsrate bei Normalpersonen. Klin. Wschr. 47, 318–324 (1969).
Wilson, I.M. and Freís, E.D.: Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide. Circulation 20, 1028–1036 (1959).
Wilson, W.R., Oktjn, R., Tetreatjlt, L., Fallís, N.: Methyldopa and hydrochlorothiazide in primary hypertension. J. Amer. med. An. 185, 819–825 (1963).
Winer, B.M.: The antihypertensive action of benzothiadiazines. Circulation 23, 211–218 (1961a).
Winer, B.M.: The antihypertensive mechanisms of salt depletion induced by hydrochlorothiazide. Circulation 24, 788–796 (1961b).
Winer, B.M., Ltjbbe, W.F., Colton, T.: Antihypertensive actions of diuretics. J. Amer. med. Ass. 204, 775–779 (1968).
Wolf, K., Gessler, U.: Experimentelle Untersuchungen zum Elektrolytstoffwechsel nach Chlorthalidonbehandlung. Arch. exp. Path. Parmakol. 247, 136–143 (1964).
Woods, J.W., Liddle, G.W., Stant, E.G., Michelakis, A.M., Brill, B.B.: Effect of an adrenal inhibitor in hypertensive patients with suppressed renin. Arch, intern. Med. 123, 366–370 (1969).
Zelisj R., Mason, D. T., Brauwald, E.: A comparison of the effects of vasodilator stimuli on peripheral resistance in vessels in normal subjects and in patients with congestive heart failure. J. clin. Invest. 47, 960–970 (1968).
Zsoter, T. T., Hart, F., Radde, I. C.: Mechanism of antihypertensive action of prolonged administration of hydrochlorothiazide in rabbit and dog. Circulation Res. 27, 717–725 (1970).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Conway, J. (1977). Antihypertensive Effect of Diuretics. In: Gross, F. (eds) Antihypertensive Agents. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 39. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66309-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-66309-3_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66311-6
Online ISBN: 978-3-642-66309-3
eBook Packages: Springer Book Archive